Inhibitory effect of a new anti-rheumatic drug T-614 on costimulatory molecule expression, cytokine production, and antigen presentation by synovial cells

Journal of Laboratory and Clinical Medicine

Volumn 133, Issue 6, 1999, Pages 566-574

  Kawakami, Atsushi ^b   Tsuboi, Masahiko ^b   Urayama, Satoshi ^b   Matsuoka, Naoki ^b   Yamasaki, Satoshi ^b   Hida, Ayumi ^b   Aoyagi, Takahiko ^b   Furuichi, Itaru ^b   Nakashima, Tomoki ^b   Migita, Kiyoshi ^b   Kawabe, Yojiro ^b   Nakashima, Munetoshi ^b   Origuchi, Tomoki ^b   Eguchi, Katsumi ^a  

^a NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0033152832     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2143(99)90186-5     Document Type: Article

References (35)

1. 1. Harris ED Jr. Rheumatoid arthritis: pathophysiology and implications for therapy. N Engl J Med 1990;322:1277-89.
2. 2. Hale LP, Martin ME, Nunley JA, Springer TA, Singer KH, Haynes BF. Immunohistologic analysis of the distribution of cell adhesion molecules within the inflammatory synovial microenvironment. Arthritis Rheum 1989;32:22-30.
3. 3. Miyasaka N, Sato K, Goto M, Sasano M, Matsuyama M, Inoue K, et al. Augmented interleukin 1 production and HLA-DR expression in the synovium of rheumatoid arthritis patients. Possible involvement in joint destruction. Arthritis Rheum 1988;31:480-6.
4. 4. Nakao H, Eguchi K, Kawakami A, Migita K, Otsubo T, Ueki Y, et al. Phenotypic characterization of lymphocytes infiltrating synovial tissue from patients with rheumatoid arthritis. J Rheumatol 1990;17:142-8.
5. 5. Reme T, Portier M, Frayssinoux F, Combe B, Miossec P, Favier F, et al. T cell receptor expression and activation of synovial lymphocyte subsets in patients with rheumatoid arthritis. Phenotyping of multiple synovial sites. Arthritis Rheum 1990;33:485-92.
6. + cell subsets in synovial fluid from patients with rheumatoid arthritis. J Rheumatol 1994;21:1003-10.
7. 7. Matsuoka N, Eguchi K, Kawakami A, Ida H, Nakashima M, Sakai M, et al. Phenotypic characteristics of T cells interacted with synovial cells. J Rheumatol 1991;18:1137-42.
8. 8. Mizokami A, Eguchi K, Kawakami A, Ida H, Kawabe Y, Tsukada T, et al. Increased population of high fluorescence 1F7 (CD26) antigen on T cells in synovial fluid of patients with rheumatoid arthritis. J Rheumatol 1996;23:2022-6.
9. 9. Arend WP, Dayer J-M. Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis. Arthritis Rheum 1990;33:305-15.
10. 10. Vocum DE, Esparza L, Dubry S, Benjamin JB, Volz R, Scuderi P. Characteristics of tumor necrosis factor production in rheumatoid arthritis. Cell Immunol 1989;122:131-45.
11. 11. Farahat MN, Yanni G, Poston R, Panani GS. Cytokine expression in synovial membranes of patients with rheumatoid arthritis and osteoarthritis. Ann Rheum Dis 1993;52:870-5.
12. 12. Guerne P-A, Zuraw BL, Vaughan JH, Garson DA, Lotz M. Synovium as a sourse of interleukin 6 in vitro: contribution to local and systemic manifestations of arthritis. J Clin Invest 1989;83:585-92.
13. 13. Houssiau FA, Devogelaer J-P, van Damme J, Nagant de Deuxchaisnes C, van Snick J. Interleukin-6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides. Arthritis Rheum 1988;31:784-8.
14. 14. Hirano T, Matsuda T, Turner M, Miyasaka N, Buchan G, Tang B, et al. Excessive production of interleukin 6/B cell stimulation factor-2 in rheumatoid arthritis. Eur J Immunol 1988;18:1797-801.
15. 15. Miyasaka N, Sato K, Hashimoto J, Kohsaka H, Yamamoto K, Goto M, et al. Constitutive production of inteleukin 6/B cell stimulatory factor-2 from inflammatory synovium. Clin Immunol Immunopathol 1989;52:238-47.
16. 16. Endo H, Akahoshi T, Takagishi K, Kashiwazaki S, Matushima K. Elevation of interleukin-8 (IL-8) levels in joint fluids of patients with rheumatoid arthritis and the induction by IL-8 of leukocyte infiltration and synovitis in rabbit joints. Lymphokine Cytokine Res 1991;10:245-52.
17. 17. Xu W-D, Finestein GS, Taetle R, Kaushansky K, Zvaifler NJ. Cytokines in chronic inflammatory arthritis. II. Granulocytemacrophage colony-stimulating factor in rheumatoid synovial effusion. J Clin Invest 1989;83:876-82.
18. 18. Williamson DJ, Begley CG, Vadas MA, Metcalf D. The detection and initial characterization of colony-stimulating factors in synovial fluid. Clin Exp Immunol 1988;72:69-73.
19. 19. Tanaka K, Shimotori T, Makino S, Akiyama Y, Inaba T, Yoshida C, et al. Pharmacological studies of the new antiinflammatory agent 3-formylamino-7-methylsulfonylamino-6-phenoxy-4H-1-benzopyran-4-one. Arzneim-Forsch/Drug Res 1992;42:935-50.
20. 20. Tanaka K, Shimotori T, Makino S, Eguchi M, Asaoka K, Kitamura R, et al. Pharmacological studies on 3-formylamino-7-methylsulfonylamino-6-phenoxy-4H-1-benzopyran-4-one (T-614), a novel antiinflammatory agent. 3rd communication: the involvement of bradykinin in its analgesic actions. J Pharmacobio-Dyn 1992;15:641-7.
21. 21. Tanaka K, Aikawa Y, Kawasaki H, Asaoka K, Inaba A, Yoshida C. Pharmacological studies on 3-formylamino-7-methylsulfonylamino-6-phenoxy-4H-1 -benzopyran-4-one (T-614), a novel antiinflammatory agent. 4th communication: inhibitory effect on the production of interleukin-1 and interleukin-6. J Pharmacobio-Dyn 1992;15:649-55.
22. 22. Hara M. Immunophermacological profile of T-614, a new anti-arthritic agent. Rev Esp Reumatol 1993;20(suppl 1):288-9.
23. 23. Tanaka K, Shimotori T, Taniguchi Y, Eguchi M, Abe C. Pharmacological studies on T-614, a novel antiinflammatory agent: effect on type II collagen-induced arthritis in DBA/1J mice and spontaneous arthritis in MRL/I mice. Int J Immunotherapy 1993;9:69-78.
24. 24. Hara M, Kashiwazaki S, Abe T, Mizushima Y, Sugawara S, Irimajiri S, et al. Therapeutic effect of T-614, a new anti-arthritic agent on rheumatoid arythritis. Program of the Sixtieth Annual Meeting of The American College of Rheumatology, Orland, 1996, s282 (abstract).
25. 25. Matsuoka N, Eguchi K, Kawakami A, Tsuboi M, Kawabe Y, Aoyagi T, et al. Inhibitory effect of clarithromycin on costimulatory molecule expression and cytokine production by synovial fibroblast-like cells. Clin Exp Immunol 1996;104:501-8.
26. 26. Eguchi K, Kawakami A, Ida H, Nakashima M, Yamashita I, Sakai M, et al. Bucillamine inhibits T cell adhesion to human endothelial cells. J Rheumatol 1992;119:1045-50.
27. 27. Aoyagi T, Eguchi K, Nakashima M, Ida H, Furuichi I, Maeda K, et al. Immunolocalization of adhesion molecules in rheumatoid and osteoarthritic synovial tissues. Acta Med Nagasaki 1993;38:62-70.
28. 28. Springer TA. Adhesion receptors of the immune system. Nature 1990;346:425-34.
29. 29. Geppert TD, Davis LS, Gur H, Wacheltz MC, Lipsky PE. Accessory cell signals involved in T-cell activation. Immunol Rev 1990;117:5-66.
30. 30. Linsley PS, Brady W, Grosmaire L, Amffo A, Damle NK, Ledbetter JA. Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation. J Exp Med 1991;173:721-30.
31. + T cells. J Exp Med 1991;173:759-62.
32. 32. Azuma M, Ito D, Yagita H, Okumura K, Phillips JH, Larier LL, et al. B70 antigen is a second ligand for CTLA-4 and CD28. Nature 1993;366:76-9.
33. 33. Freeman GJ, Gribben JG, Boussiotis VA, Ng JW, Restivo VA Jr, Lombard LA, et al. Cloning of B7-2: a CTLA-4 counter receptor that costimulates human T cell proliferation. Science 1993;262:909-11.
34. + T lymphocytes. J Immunol 1992;148:1985-92.
35. 35. Bohmig GA, Kovarik J, Holter W, Pohanka E, Zlabinger GJ. Specific down-regulation of proliferative T cell alloresponsiveness by interference with CD2/LFA-3 and LFA-1/ICAM-1 in vitro. J Immunol 1994;152:3720-8.